These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34941931)

  • 1. Blocking of inflammatory heparan sulfate domains by specific antibodies is not protective in experimental glomerulonephritis.
    van Gemst JJ; Passmann NJHG; Rops ALWMM; van Kuppevelt TH; Berden JH; Loeven MA; Rabelink TJ; Smeets B; van der Vlag J
    PLoS One; 2021; 16(12):e0261722. PubMed ID: 34941931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential binding of chemokines CXCL1, CXCL2 and CCL2 to mouse glomerular endothelial cells reveals specificity for distinct heparan sulfate domains.
    van Gemst JJ; Kouwenberg M; Rops ALWMM; van Kuppevelt TH; Berden JH; Rabelink TJ; Loeven MA; van der Vlag J
    PLoS One; 2018; 13(9):e0201560. PubMed ID: 30248108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of heparan sulfate in the glomerular endothelial glycocalyx decreases leukocyte influx during experimental glomerulonephritis.
    Rops AL; Loeven MA; van Gemst JJ; Eversen I; Van Wijk XM; Dijkman HB; van Kuppevelt TH; Berden JH; Rabelink TJ; Esko JD; van der Vlag J
    Kidney Int; 2014 Nov; 86(5):932-42. PubMed ID: 24759151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 prevent crescent formation in rat autoimmune glomerulonephritis.
    Nishikawa K; Guo YJ; Miyasaka M; Tamatani T; Collins AB; Sy MS; McCluskey RT; Andres G
    J Exp Med; 1993 Mar; 177(3):667-77. PubMed ID: 8094735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glomerular endothelial glycocalyx-derived heparan sulfate inhibits glomerular leukocyte influx and attenuates experimental glomerulonephritis.
    Maciej-Hulme ML; Van Gemst JJ; Sanderson P; Rops ALWMM; Berden JH; Smeets B; Amster IJ; Rabelink TJ; Van Der Vlag J
    Front Mol Biosci; 2023; 10():1177560. PubMed ID: 37325479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparan sulfate staining of the glomerular basement membrane in relation to circulating anti-DNA and anti-heparan sulfate reactivity: a longitudinal study in NZB/W F1 mice.
    Hylkema MN; van Bruggen MC; van de Lagemaat R; Kramers K; Berden JH; Smeenk RJ
    J Autoimmun; 1996 Feb; 9(1):41-50. PubMed ID: 8845053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of glomerular heparan sulphate domains in murine and human lupus nephritis.
    Rops AL; van den Hoven MJ; Bakker MA; Lensen JF; Wijnhoven TJ; van den Heuvel LP; van Kuppevelt TH; van der Vlag J; Berden JH
    Nephrol Dial Transplant; 2007 Jul; 22(7):1891-902. PubMed ID: 17550924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycosaminoglycans and fucoidan have a protective effect on experimental glomerulonephritis.
    Buijsers B; Maciej-Hulme M; Jacobs M; Bebber MB; de Graaf M; Salmenov R; Parr N; Rabelink TJ; Nijenhuis T; van der Vlag J
    Front Mol Biosci; 2023; 10():1223972. PubMed ID: 37475889
    [No Abstract]   [Full Text] [Related]  

  • 9. Heparanase Is Essential for the Development of Acute Experimental Glomerulonephritis.
    Garsen M; Benner M; Dijkman HB; van Kuppevelt TH; Li JP; Rabelink TJ; Vlodavsky I; Berden JH; Rops AL; Elkin M; van der Vlag J
    Am J Pathol; 2016 Apr; 186(4):805-15. PubMed ID: 26873445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-1 receptor antagonist ameliorates experimental anti-glomerular basement membrane antibody-associated glomerulonephritis.
    Tang WW; Feng L; Vannice JL; Wilson CB
    J Clin Invest; 1994 Jan; 93(1):273-9. PubMed ID: 7904269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monocyte chemoattractant protein-1 mediates monocyte/macrophage influx in anti-thymocyte antibody-induced glomerulonephritis.
    Wenzel U; Schneider A; Valente AJ; Abboud HE; Thaiss F; Helmchen UM; Stahl RA
    Kidney Int; 1997 Mar; 51(3):770-6. PubMed ID: 9067909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-heparan sulfate antibody and functional loss of glomerular heparan sulfate proteoglycans in lupus nephritis.
    Kim HJ; Hong YH; Kim YJ; Kim HS; Park JW; Do JY; Kim KJ; Bae SW; Kim CW; Lee CK
    Lupus; 2017 Jul; 26(8):815-824. PubMed ID: 28420046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparan sulfate domains on cultured activated glomerular endothelial cells mediate leukocyte trafficking.
    Rops AL; van den Hoven MJ; Baselmans MM; Lensen JF; Wijnhoven TJ; van den Heuvel LP; van Kuppevelt TH; Berden JH; van der Vlag J
    Kidney Int; 2008 Jan; 73(1):52-62. PubMed ID: 17914352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of GBM heparan sulfate proteoglycan core protein and side chains in human glomerular diseases.
    van den Born J; van den Heuvel LP; Bakker MA; Veerkamp JH; Assmann KJ; Weening JJ; Berden JH
    Kidney Int; 1993 Feb; 43(2):454-63. PubMed ID: 8441243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glomerular injury induced by antibodies against heparan sulfate proteoglycan (HSPG) derived from PYS 2 cells.
    Yoshida F; Matsuo S; Hiramatsu T; Okura T; Yuzawa Y; Watanabe Y; Sakamoto N; Matsuo S
    Nihon Jinzo Gakkai Shi; 1989 Feb; 31(2):135-43. PubMed ID: 2525633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue factor initiates glomerular fibrin deposition and promotes major histocompatibility complex class II expression in crescentic glomerulonephritis.
    Erlich JH; Holdsworth SR; Tipping PG
    Am J Pathol; 1997 Mar; 150(3):873-80. PubMed ID: 9060825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in glomerular heparan sulfate correlates with complement deposition and albuminuria in active Heymann nephritis.
    Raats CJ; Luca ME; Bakker MA; Van Der Wal A; Heeringa P; Van Goor H; Van Den Born J; De Heer E; Berden JH
    J Am Soc Nephrol; 1999 Aug; 10(8):1689-99. PubMed ID: 10446936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased PMN accumulation and glomerular damage by clodronate liposome treatment in PMN-dependent anti-GBM nephritis in mice.
    Feith GW; Bogman MJ; Assmann KJ; van Gompel AP; Schalkwijk J; van Rooijen N; Koene RA
    Exp Nephrol; 1997; 5(4):301-4. PubMed ID: 9259184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage-induced glomerular fibrin deposition in experimental glomerulonephritis in the rabbit.
    Holdsworth SR; Tipping PG
    J Clin Invest; 1985 Oct; 76(4):1367-74. PubMed ID: 4056035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to basement membrane heparan sulfate proteoglycans bind to the laminae rarae of the glomerular basement membrane (GBM) and induce subepithelial GBM thickening.
    Miettinen A; Stow JL; Mentone S; Farquhar MG
    J Exp Med; 1986 May; 163(5):1064-84. PubMed ID: 2939168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.